Featured publications

• α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment

  Esteller-Gauxax, Diana; Perez Millan, Agnes; Sarto, Jordi; Puey, Roger; Guillen Soley, Nuria;

  (...)

  Auge Fradera, Josep Maria; Antonell, Anna; Sanchez-Valle, Raquel; Llado, Albert; Balasa, Mircea.

  See complete list of authors

  Reference:

  NEUROLOGY 2025.

• Blood-based biomarkers for Alzheimer's disease: positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology.

  Suárez-Calvet M; Abdelnour C; Alcolea D; Mendióroz-Iriarte M; Balasa M;

  Morenas-Rodríguez E; Puig-Pijoan A; Sánchez-Juan P; Villarejo A; Sánchez-Valle R;.

  Reference:

  NEUROLOGIA 2025.

• Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

  Bateman, Randall J; Li, Yan; McDade, Eric M; Llibre-Guerra, Jorge J; Clifford, David B;

  (...)

  Levin, Johannes; Lopera, Francisco; Roh, JeeHoon; Rosa-Neto, Pedro; Schofield, Peter R.

  See complete list of authors

  Reference:

  LANCET NEUROLOGY 2025.

• Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study

  Tort-Merino, Adria; Perez-Millan, Agnes; Falgas, Neus; Borrego-ecija, Sergi; Esteller, Diana;

  (...)

  Illan-Gala, Ignacio; Balasa, Mircea; Llado, Albert; Rami, Lorena; Sanchez-Valle, Raquel.

  See complete list of authors

  Reference:

  Alzheimers & Dementia 2025.

• Association of Initial Side of Brain Atrophy With Clinical Features and Disease Progression in Patients With GRN Frontotemporal Dementia

  Borrego-Ecija, S; Juncà-Parella, J; Vandebergh, M; Millan, AP; Balasa, M;

  (...)

  Moreno, F; Borroni, B; Rademakers, R; Rohrer, JD; Sánchez-Valle, R.

  See complete list of authors

  Reference:

  NEUROLOGY 2024.

• Clinical and research application of fluid bio markers in autosomal dominant Alzheimer's disease and Down syndrome

  Carmona-Iragui, M; 'Connor, AO; Llibre-Guerra, J; Lao, PT; Ashton, NJ;

  Fortea, J; Sánchez-Valle, R.

  Reference:

  EBioMedicine 2024.

• Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer's disease

  Falgàs, N; Peña-González, M; Val-Guardiola, A; Pérez-Millan, A; Guillén, N;

  (...)

  Morales-Ruiz, M; Bargalló, N; Muñoz-Moreno, E; Grinberg, LT; Sánchez-Valle, R.

  See complete list of authors

  Reference:

  Alzheimers & Dementia 2024.

• Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity

  Borrego-Écija, S; Pérez-Millan, A; Antonell, A; Fort-Aznar, L; Kaya-Tilki, E;

  (...)

  Vitorica, J; Venero, JL; Deierborg, T; Boza-Serrano, A; Sánchez-Valle, R.

  See complete list of authors

  Reference:

  Alzheimers & Dementia 2024.

• Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects

  Rami, L; León, M; Valech, N; Coll-Padrós, N; Bosch, B;

  (...)

  Salinero, A; Pérez-Millan, A; Molinuevo, JL; Sánchez-Valle, R; Tort-Merino, A.

  See complete list of authors

  Reference:

  NEUROPSYCHOLOGY 2023.

• Classifying Alzheimer's disease and frontotemporal dementia using machine learning with cross-sectional and longitudinal magnetic resonance imaging data

  Pérez-Millan, A; Contador, J; Junc-Parella, J; Bosch, B; Borrell, L;

  (...)

  Rami, L; Balasa, M; Llad, A; Sánchez-Valle, R; Sala-Llonch, R.

  See complete list of authors

  Reference:

  HUMAN BRAIN MAPPING 2023.